BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 29212801)

  • 1. Roles of high-mobility group box 1 and thrombin in murine pulmonary fibrosis and the therapeutic potential of thrombomodulin.
    Kida T; Seno T; Nagahara H; Inoue T; Nakabayashi A; Kukida Y; Fujioka K; Fujii W; Wada M; Kohno M; Kawahito Y
    Am J Physiol Lung Cell Mol Physiol; 2018 Mar; 314(3):L473-L483. PubMed ID: 29212801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of the receptor for advanced glycation end-products in lung fibrosis.
    He M; Kubo H; Ishizawa K; Hegab AE; Yamamoto Y; Yamamoto H; Yamaya M
    Am J Physiol Lung Cell Mol Physiol; 2007 Dec; 293(6):L1427-36. PubMed ID: 17951314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Cell Apoptosis and Amelioration of Pulmonary Fibrosis by Thrombomodulin.
    Fujiwara K; Kobayashi T; Fujimoto H; Nakahara H; D'Alessandro-Gabazza CN; Hinneh JA; Takahashi Y; Yasuma T; Nishihama K; Toda M; Kajiki M; Takei Y; Taguchi O; Gabazza EC
    Am J Pathol; 2017 Oct; 187(10):2312-2322. PubMed ID: 28739343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of high mobility group box1 in pulmonary fibrosis.
    Hamada N; Maeyama T; Kawaguchi T; Yoshimi M; Fukumoto J; Yamada M; Yamada S; Kuwano K; Nakanishi Y
    Am J Respir Cell Mol Biol; 2008 Oct; 39(4):440-7. PubMed ID: 18441281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Icariside Ⅱ attenuates bleomycin-induced pulmonary fibrosis by modulating macrophage polarization.
    Deng L; Ouyang B; Shi H; Yang F; Li S; Xie C; Du W; Hu L; Wei Y; Dong J
    J Ethnopharmacol; 2023 Dec; 317():116810. PubMed ID: 37331450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The novel inhibitor PRI-724 for Wnt/β-catenin/CBP signaling ameliorates bleomycin-induced pulmonary fibrosis in mice.
    Okazaki H; Sato S; Koyama K; Morizumi S; Abe S; Azuma M; Chen Y; Goto H; Aono Y; Ogawa H; Kagawa K; Nishimura H; Kawano H; Toyoda Y; Uehara H; Kouji H; Nishioka Y
    Exp Lung Res; 2019 Sep; 45(7):188-199. PubMed ID: 31298961
    [No Abstract]   [Full Text] [Related]  

  • 7. Tenofovir alafenamide fumarate attenuates bleomycin-induced pulmonary fibrosis by upregulating the NS5ATP9 and TGF-β1/Smad3 signaling pathway.
    Li L; Zhao J; Zhou L; Chen J; Ma Y; Yu Y; Cheng J
    Respir Res; 2019 Jul; 20(1):163. PubMed ID: 31331325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of andrographolide on the concentration of cytokines in BALF and the expressions of type I and III collagen mRNA in lung tissue in bleomycin-induced rat pulmonary fibrosis].
    Zhu HL; Huang CL; Wang WJ; Zhan XQ; Fan XM
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Jul; 27(7):725-9. PubMed ID: 21722520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective roles of pulmonary rehabilitation mixture in experimental pulmonary fibrosis in vitro and in vivo.
    Zhang L; Ji YX; Jiang WL; Lv CJ
    Braz J Med Biol Res; 2015 Jun; 48(6):545-52. PubMed ID: 25992646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arsenic trioxide inhibits transforming growth factor-β1-induced fibroblast to myofibroblast differentiation in vitro and bleomycin induced lung fibrosis in vivo.
    Luo F; Zhuang Y; Sides MD; Sanchez CG; Shan B; White ES; Lasky JA
    Respir Res; 2014 Apr; 15(1):51. PubMed ID: 24762191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total extract of Yupingfeng attenuates bleomycin-induced pulmonary fibrosis in rats.
    Li L; Li D; Xu L; Zhao P; Deng Z; Mo X; Li P; Qi L; Li J; Gao J
    Phytomedicine; 2015 Jan; 22(1):111-9. PubMed ID: 25636879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycyrrhizic acid, as an inhibitor of HMGB1, alleviates bleomycin-induced pulmonary toxicity in mice through the MAPK and Smad3 pathways.
    Zhu ZH; Li X; He LF; Cai HF; Ye B; Wu ZM
    Immunopharmacol Immunotoxicol; 2021 Aug; 43(4):461-470. PubMed ID: 34142927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of SMOC2 reduces bleomycin (BLM)-induced pulmonary fibrosis by inhibition of TGF-β1/SMADs pathway.
    Luo L; Wang CC; Song XP; Wang HM; Zhou H; Sun Y; Wang XK; Hou S; Pei FY
    Biomed Pharmacother; 2018 Sep; 105():841-847. PubMed ID: 30021376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gefitinib Inhibits Bleomycin-Induced Pulmonary Fibrosis via Alleviating the Oxidative Damage in Mice.
    Li L; Cai L; Zheng L; Hu Y; Yuan W; Guo Z; Li W
    Oxid Med Cell Longev; 2018; 2018():8249693. PubMed ID: 29849916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-Mobility Group Box 1 Mediates Epithelial-to-Mesenchymal Transition in Pulmonary Fibrosis Involving Transforming Growth Factor-β1/Smad2/3 Signaling.
    Li LC; Li DL; Xu L; Mo XT; Cui WH; Zhao P; Zhou WC; Gao J; Li J
    J Pharmacol Exp Ther; 2015 Sep; 354(3):302-9. PubMed ID: 26126535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Necrostatin-1 Alleviates Bleomycin-Induced Pulmonary Fibrosis and Extracellular Matrix Expression in Interstitial Pulmonary Fibrosis.
    Mou F; Mou C
    Med Sci Monit; 2020 Feb; 26():e919739. PubMed ID: 32019905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Follistatin-Like 1 Promotes Bleomycin-Induced Pulmonary Fibrosis through the Transforming Growth Factor Beta 1/Mitogen-Activated Protein Kinase Signaling Pathway.
    Jin YK; Li XH; Wang W; Liu J; Zhang W; Fang YS; Zhang ZF; Dai HP; Ning W; Wang C
    Chin Med J (Engl); 2018 Aug; 131(16):1917-1925. PubMed ID: 30082522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The melatonin agonist ramelteon attenuates bleomycin-induced lung fibrosis by suppressing the NLRP3/TGF-Β1/HMGB1 signaling pathway.
    Aydin P; Aksakalli-Magden ZB; Civelek MS; Karabulut-Uzuncakmak S; Mokhtare B; Ozkaraca M; Alper F; Halici Z
    Adv Med Sci; 2023 Sep; 68(2):322-331. PubMed ID: 37716182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Derrone Targeting the TGF Type 1 Receptor Kinase Improves Bleomycin-Mediated Pulmonary Fibrosis through Inhibition of Smad Signaling Pathway.
    Molagoda IMN; Sanjaya SS; Lee KT; Choi YH; Lee JH; Lee MH; Kang CH; Lee CM; Kim GY
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fucoxanthin inhibits profibrotic protein expression in vitro and attenuates bleomycin-induced lung fibrosis in vivo.
    Ma SY; Park WS; Lee DS; Choi G; Yim MJ; Lee JM; Jung WK; Park SG; Seo SK; Park SJ; Han IY; Choi YH; Choi IW
    Eur J Pharmacol; 2017 Sep; 811():199-207. PubMed ID: 28642129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.